Compare TTK HEALTHCARE with STRIDES PHARMA SCIENCE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs STRIDES PHARMA SCIENCE - Comparison Results

STRIDES PHARMA SCIENCE 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE STRIDES PHARMA SCIENCE TTK HEALTHCARE/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 12.0 43.4 27.6% View Chart
P/BV x 1.7 2.0 85.7% View Chart
Dividend Yield % 0.9 0.2 370.9%  

Financials

 TTK HEALTHCARE   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
STRIDES PHARMA SCIENCE
Mar-18
TTK HEALTHCARE/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs1,2151,147 105.9%   
Low Rs610642 95.0%   
Sales per share (Unadj.) Rs444.4317.2 140.1%  
Earnings per share (Unadj.) Rs17.27.8 219.9%  
Cash flow per share (Unadj.) Rs27.625.1 110.3%  
Dividends per share (Unadj.) Rs5.002.00 250.0%  
Dividend yield (eoy) %0.50.2 245.1%  
Book value per share (Unadj.) Rs177.9274.3 64.9%  
Shares outstanding (eoy) m14.1389.50 15.8%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x2.12.8 72.8%   
Avg P/E ratio x52.9114.0 46.4%  
P/CF ratio (eoy) x33.035.7 92.5%  
Price / Book Value ratio x5.13.3 157.2%  
Dividend payout %29.025.5 113.7%   
Avg Mkt Cap Rs m12,89480,058 16.1%   
No. of employees `0002.32.5 92.2%   
Total wages/salary Rs m1,3074,341 30.1%   
Avg. sales/employee Rs Th2,715.711,325.8 24.0%   
Avg. wages/employee Rs Th565.31,731.4 32.7%   
Avg. net profit/employee Rs Th105.4280.1 37.6%   
INCOME DATA
Net Sales Rs m6,27928,394 22.1%  
Other income Rs m78941 8.2%   
Total revenues Rs m6,35629,334 21.7%   
Gross profit Rs m4963,965 12.5%  
Depreciation Rs m1471,540 9.5%   
Interest Rs m341,962 1.7%   
Profit before tax Rs m3931,403 28.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-168 0.0%   
Extraordinary Inc (Exp) Rs m0-436 0.0%   
Tax Rs m14997 153.0%   
Profit after tax Rs m244702 34.7%  
Gross profit margin %7.914.0 56.5%  
Effective tax rate %37.96.9 547.0%   
Net profit margin %3.92.5 157.0%  
BALANCE SHEET DATA
Current assets Rs m2,71724,836 10.9%   
Current liabilities Rs m1,57118,993 8.3%   
Net working cap to sales %18.320.6 88.7%  
Current ratio x1.71.3 132.3%  
Inventory Days Days3271 45.3%  
Debtors Days Days47113 41.1%  
Net fixed assets Rs m99134,289 2.9%   
Share capital Rs m141895 15.8%   
"Free" reserves Rs m2,37323,651 10.0%   
Net worth Rs m2,51424,546 10.2%   
Long term debt Rs m315,513 0.0%   
Total assets Rs m4,15865,437 6.4%  
Interest coverage x12.61.7 735.6%   
Debt to equity ratio x00.6 0.2%  
Sales to assets ratio x1.50.4 348.0%   
Return on assets %6.74.1 163.9%  
Return on equity %9.72.9 338.9%  
Return on capital %16.96.9 245.7%  
Exports to sales %3.60-   
Imports to sales %0.50-   
Exports (fob) Rs m225NA-   
Imports (cif) Rs m31NA-   
Fx inflow Rs m22515,697 1.4%   
Fx outflow Rs m71735 9.7%   
Net fx Rs m15414,962 1.0%   
CASH FLOW
From Operations Rs m1731,871 9.3%  
From Investments Rs m975,826 1.7%  
From Financial Activity Rs m-307-10,157 3.0%  
Net Cashflow Rs m-38-2,615 1.4%  

Share Holding

Indian Promoters % 65.4 27.7 236.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 37.8 9.8%  
FIIs % 5.2 8.6 60.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 25.9 99.6%  
Shareholders   12,723 56,241 22.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   PIRAMAL ENTERPRISES  GSK PHARMA  DR. DATSONS LABS  DR. REDDYS LAB  NOVARTIS  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Nifty is Weak but Smallcaps Can Outperform(Momentum Moves)

The market see-sawed during the week with both the bulls and bears swinging it out. But in the end, it was the bears who won. The Nifty ended the day, the week, and the month at 14,529.15.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 71.7% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, TTK HEALTHCARE has posted a net profit of Rs 77 m (up 71.7% YoY). Sales on the other hand came in at Rs 2 bn (up 8.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (3QFY21); Net Profit Down 46.4% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, STRIDES PHARMA SCIENCE has posted a net profit of Rs 621 m (down 46.4% YoY). Sales on the other hand came in at Rs 8 bn (up 13.6% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY21); Net Profit Up 184.5% (Quarterly Result Update)

Aug 20, 2020 | Updated on Aug 20, 2020

For the quarter ended June 2020, STRIDES PHARMA SCIENCE has posted a net profit of Rs 1 bn (up 184.5% YoY). Sales on the other hand came in at Rs 8 bn (up 14.0% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (2QFY20); Net Profit Up 2778.7% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 2 bn (up 2778.7% YoY). Sales on the other hand came in at Rs 7 bn (down 2.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Feb 26, 2021 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - JUBILANT LIFE SCIENCES COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS